NCT07130643 2025-08-19Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast CancerHubei Cancer HospitalPhase 2 Active not recruiting40 enrolled